O
Ophélia Godin
Researcher at University of Paris
Publications - 131
Citations - 3353
Ophélia Godin is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Bipolar disorder. The author has an hindex of 29, co-authored 106 publications receiving 2671 citations. Previous affiliations of Ophélia Godin include Paris 12 Val de Marne University & Pierre-and-Marie-Curie University.
Papers
More filters
Journal ArticleDOI
Sleep quality, chronotype and metabolic syndrome components in bipolar disorders during the remission period: Results from the FACE-BD cohort
Ophélia Godin,Chantal Henry,Marion Leboyer,Jean-Michel Azorin,Valerie Aubin,Frank Bellivier,Mircea Polosan,Philippe Courtet,Sébastien Gard,Jean-Pierre Kahn,Joséphine Loftus,Christine Passerieux,Dominique Costagliola,Bruno Etain +13 more
TL;DR: The findings contribute to the scant literature on the relationship between sleep quality, chronotype and cardiometabolic components in euthymic individuals with BD and highlight the need to improve quality of sleep and patient education about healthier sleep-hygiene practices.
Journal ArticleDOI
Centres Experts Schizophrénie, un outil pour le soin et la recherche : retour sur 10 ans d’expérience
F. Schürhoff,F. Schürhoff,Guillaume Fond,Fabrice Berna,E. Bulzacka,Ophélia Godin,L. Boyer,David Misdrahi,M. Andrianarisoa,Lore Brunel,N Coulon,Bruno Aouizerate,Delphine Capdevielle,Isabelle Chereau,Thierry d'Amato,Caroline Dubertret,Julien Dubreucq,Catherine Faget,F. Gabayet,Jasmina Mallet,Romain Rey,C. Lançon,Christine Passerieux,A. Schandrin,Mathieu Urbach,Pierre Vidailhet,Marion Leboyer,Pierre-Michel Llorca +27 more
TL;DR: Un retour sur les 10 ans d’experience du reseau national des 10 centres experts schizophrenie Francais is proposed to be proposed, a travers une revue des principales publications scientifiques, toisent a formuler plusieurs recommandations.
Journal ArticleDOI
Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection.
Nora Hamdani,Nora Hamdani,Djaouida Bengoufa,Ophélia Godin,Raphaël Doukhan,Emmanuel Le Guen,Emmanuel Le Guen,Claire Daban-Huard,Claire Daban-Huard,Meriem Bennabi,Marine Delavest,Jean Pierre Lepine,Wahid Boukouaci,H. Laouamri,Josselin Houenou,Stéphane Jamain,Jean Romain Richard,Philippe Lecorvosier,Robert H. Yolken,Krishnamoorthy Rajagopal,Marion Leboyer,Marion Leboyer,Ryad Tamouza +22 more
TL;DR: Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders.
Journal ArticleDOI
Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort
Guillaume Fond,Laurent Boyer,M. Andrianarisoa,Ophélia Godin,E. Bulzacka,Fabrice Berna,Lore Brunel,N Coulon,Bruno Aouizerate,Delphine Capdevielle,Isabelle Chereau,Thierry d'Amato,Hélène Denizot,Caroline Dubertret,Julien Dubreucq,Catherine Faget,Sylvain Leignier,Jasmina Mallet,David Misdrahi,Romain Rey,Christophe Lançon,Christine Passerieux,A. Schandrin,Mathieu Urbach,Pierre Vidailhet,Marion Leboyer,Franck Schürhoff,Pierre-Michel Llorca +27 more
TL;DR: The present findings suggest that community‐dwelling SZ outpatients report a high rate of self‐reported physical pain, associated with headache, depression and anxiety and history of childhood trauma.
Posted Content
Differential effects of childhood trauma and cannabis use disorders in ă patients suffering from schizophrenia
Grégoire Baudin,Ophélia Godin,Mohamed Lajnef,Bruno Aouizerate,Fabrice Berna,Lore Brunel,Delphine Capdevielle,Isabelle Chereau,Jean-Michel Dorey,C. Dubertret,Julien Dubreucq,Catherine Faget,Guillaume Fond,F. Gabayet,H. Laouamri,C. Lançon,Y. Le Strat,A.M. Tronche,David Misdrahi,Romain Rey,Christine Passerieux,A. Schandrin,Mathieu Urbach,P. Vidalhet,P.-M. Llorca,F. Schürhoff,Fondamental Acad Ctr Expertise +26 more
TL;DR: In this article, the main effect of each of these two environmental factors on the a clinical expression of the disease using a large set of variables, and a tested whether and how cannabis and CT interact to influence the a course and the presentation of the illness.